Back to 
Qube Research & Technologies Ltd
Qube Research & Technologies Ltd
ALT
Showing 0 of 10 quarters
Position history for Qube Research & Technologies Ltd's holdings in Altimmune, Inc.
No. Qube Research & Technologies exited its ALT (Altimmune) position in Q4 2023. Its Q3 2023 13F listed 178,697 shares worth $464,612. Qube Research & Technologies first reported ALT in Q3 2020 and held it in 8 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.